Antimicrobial Photodynamic Therapy in the Control of COVID-19
Adelaide Almeida, M. Amparo F. Faustino, Maria G. P. M. S. Neves
Abstract
Antimicrobial photodynamic therapy (aPDT), using well known, safe and cost-effective photosensitizers, such as phenothiazines, e.g., methylene blue (MB), or porphyrins, e.g., protoporphyrin-IX (PP-IX), might help to mitigate the COVID-19 either to prevent infections or to develop photoactive fabrics (e.g., masks, suits, gloves) to disinfect surfaces, air and wastewater, under artificial light and/or natural sunlight.
Topics & Concepts
Photodynamic therapyProtoporphyrin IXAntimicrobialMethylene blueCoronavirus disease 2019 (COVID-19)PhotosensitizerSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)2019-20 coronavirus outbreakMedicineChemistryMicrobiologyPhotochemistryVirologyPhotocatalysisOrganic chemistryBiologyInternal medicineInfectious disease (medical specialty)OutbreakDiseaseCatalysisPhotodynamic Therapy Research StudiesNanoplatforms for cancer theranosticsDental Research and COVID-19